tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ELDN Stock Latest News

Eledon Pharmaceuticals Enacts Key Proposals and Board Changes
Company AnnouncementsEledon Pharmaceuticals Enacts Key Proposals and Board Changes
12d ago
8K
ELDN
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
PremiumPress Releases
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
20d ago
ELDN
Eledon gives data on tegoprubart for rejection prevention in kidney transplant
PremiumThe Fly
Eledon gives data on tegoprubart for rejection prevention in kidney transplant
2M ago
ELDN
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
PremiumPress Releases
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
2M ago
ELDN
Eledon Pharmaceuticals files to sell 21.1M shares of common stock for holders
PremiumThe Fly
Eledon Pharmaceuticals files to sell 21.1M shares of common stock for holders
2M ago
ELDN
Eledon Pharmaceuticals price target lowered to $28 from $39 at Ladenburg
PremiumThe FlyEledon Pharmaceuticals price target lowered to $28 from $39 at Ladenburg
2M ago
ELDN
Eledon Pharmaceuticals reports Q1 EPS *34c(, consensus (38c)
PremiumThe Fly
Eledon Pharmaceuticals reports Q1 EPS *34c(, consensus (38c)
2M ago
ELDN
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
PremiumPress Releases
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
2M ago
ELDN
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
PremiumPress Releases
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
2M ago
ELDN
Eledon Pharmaceuticals price target raised to $16 from $13 at H.C. Wainwright
PremiumThe Fly
Eledon Pharmaceuticals price target raised to $16 from $13 at H.C. Wainwright
3M ago
ELDN
Eledon Pharmaceuticals Secures $50M Through Private Placement
PremiumCompany Announcements
Eledon Pharmaceuticals Secures $50M Through Private Placement
3M ago
8K
ELDN
Eledon Pharmaceuticals to sell 13.1M shares at $2.37 in private placement
PremiumThe Fly
Eledon Pharmaceuticals to sell 13.1M shares at $2.37 in private placement
3M ago
ELDN
Eledon announces first participant received islet cell transplant
PremiumThe FlyEledon announces first participant received islet cell transplant
3M ago
ELDN
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
PremiumPress Releases
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
3M ago
ELDN
These 2 ‘Strong Buy’ Penny Stocks Are Poised for Over 300% Gains, Say Analysts
PremiumStock Analysis & Ideas
These 2 ‘Strong Buy’ Penny Stocks Are Poised for Over 300% Gains, Say Analysts
3M ago
ABOS
ELDN
Eledon Pharmaceuticals Risks Shareholder Equity Dilution Amidst Private Placement and Potential Stock Issuances
PremiumCompany Announcements
Eledon Pharmaceuticals Risks Shareholder Equity Dilution Amidst Private Placement and Potential Stock Issuances
4M ago
ELDN
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
PremiumPress Releases
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
4M ago
ELDN
Eledon Pharmaceuticals reports Q4 EPS (32c), consensus (39c)
PremiumThe Fly
Eledon Pharmaceuticals reports Q4 EPS (32c), consensus (39c)
4M ago
ELDN
Is ELDN a Buy, Before Earnings?
PremiumPre-Earnings
Is ELDN a Buy, Before Earnings?
4M ago
ELDN
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
PremiumPress ReleasesEledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
4M ago
ELDN
Eledon announces use of tegoprubart in transplant of genetically modified kidney
PremiumThe Fly
Eledon announces use of tegoprubart in transplant of genetically modified kidney
4M ago
ELDN
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
PremiumPress Releases
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
4M ago
ELDN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >